Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

China · Delayed Price · Currency is CNY

3.450

+0.020 (0.58%)

Jul 3, 2026, 3:04 PM CST

-65.05% (1Y)

Market Cap	2.28B -58.4%
Revenue (ttm)	283.34M -9.2%
Net Income	-133.66M
EPS	-0.20
Shares Out	659.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,976,500
Open	3.340
Previous Close	3.430
Day's Range	3.340 - 3.500
52-Week Range	3.040 - 11.670
Beta	-0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:002581

Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. The company is involved in the chemical raw materials, chemical product manufacturing, and biopharmaceutical manufacturing; production and sales of medicines. It also offers operating chemical products, such as trimethyl ester and triethyl ester. The company was founded in 2000 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2000

Employees 492

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002581

Full Company Profile

Financial Performance

In 2025, SHE:002581's revenue was 274.81 million, a decrease of -23.75% compared to the previous year's 360.41 million. Losses were -116.28 million, -15.32% less than in 2024.

Financial Statements